MSK researchers are helping to map the landscape of viruses that infect us all, and to analyze the impact they have on human health and disease.

MSK experts believe that giving the targeted drug asciminib to patients with chronic myeloid leukemia at the beginning of ...

The Memorial Sloan Kettering Cancer Center (MSK) community extends our congratulations to Board of Trustees member David M. Rubenstein, who received the Presidential Medal of Freedom — the nation’s ...

Research at MSK Our research impact Research topics Core facilities & resources ...

A team led by surgeon-scientist Dr. Vinod Balachandran identified the molecular pathway involved in the formation of tertiary lymphoid structures. Therapeutically targeting this pathway could ...

Ready to start planning your care? Call us at 800-525-2225 to make an appointment.

The immune system responds to viral infections by introducing a complex interplay of immune cells and factors, whose goal is to eliminate the intruding pathogen. One such effector cell in the ...

The goal of our laboratory is to understand when, why, and how immune cells become unresponsive to tumors or self-destructive in autoimmune diseases. We develop genetic cancer mouse models that mimic ...

According to the latest statistics from the American Cancer Society, incidence rates of lung cancer are now higher in women than in men among people younger than 65 years. Overall, though, the news ...

Our laboratory uses a combination of structural biology and biophysical techniques to discover how ion channels and membrane-embedded enzymes function at the atomic level. The proteins we study are ...